

IN BRIEF: ImmuPharma appoints COO Tim Franklin to board of directors


AIM WINNERS & LOSERS: Pantheon up on resource upgrade, farmout talks


IN BRIEF: Immupharma moves step closer to Lupazor phase three trial


UK shareholder meetings calendar - next 7 days


EXECUTIVE CHANGES: Gresham House Strategic plots future as chair exits


TRADING UPDATES: Keystone Law and Checkit post annual revenue growth


(Sharecast News) - Specialist drug discovery and development company ImmuPharma updated the market on the new optimised international phase 3 trial of...


AIM WINNERS & LOSERS: Tavistock Rises As Tips Annual Earnings Climb